FXR2 and neoplasm: Dox-induced FXR1 downregulation significantly reduced tumor growth in the TP53/FXR2 co-deleted cell line HL-60-derived xenograft model (Figure 1G), but had no impact on growth in the copy-number-normal cell A549-derived xenograft (Figure 1—figure supplement 3C).